For many retinal diseases, including age-related macular degeneration (AMD), glaucoma,
and diabetic retinopathy (DR), the exact pathogenesis is still unclear. Moreover, the currently …

Glaucoma is a leading cause of irreversible blindness worldwide, caused by the gradual
degeneration of retinal ganglion cells and their axons. While glaucoma is primarily …

The ocular drug discovery field has evidenced significant advancement in the past decade.
The FDA approvals of Rhopressa, Vyzulta, and Roclatan for glaucoma, Brolucizumab for wet …

Exosomes are membrane-bound tiny particles that are released by all live cells that contain
multiple signal molecules and extensively participate in numerous normal physical activities …

Glaucoma as the leading neurodegenerative disease leads to blindness in 3.6 million
people aged 50 years and older worldwide. For many decades, glaucoma therapy has …

Melatonin, an indoleamine, is synthesized mainly in the pineal gland in a circadian fashion,
but it is produced in many other organs, including the retina, which seems to be especially …

Optic neuropathies are a major cause of visual impairment due to retinal ganglion cell
(RGC) degeneration. Human induced-pluripotent stem cells (iPSCs) represent a powerful …

Primary open-angle glaucoma (POAG) is a genetically, physiologically, and phenotypically
complex neurodegenerative disorder. This study addressed the expanding collection of …

Introduction: Glaucoma is one of the main leading causes of irreversible blindness in the
world. The treatment of this disease relies on the use of drugs able to reduce/control the …

Glaucoma is a permanent damage of optic nerves which cause of partial or complete visual
loss. This work presents a glaucoma detection scheme by measuring CDR from fundus …